Lannett Investors Seek Final OK Of $5.8M Price-Fix Probe Suit

By Sydney Price · March 16, 2026, 7:40 PM EDT

Former executives of pharmaceutical company Lannett Inc. and a class of investors have asked a Pennsylvania federal court to grant final approval to their $5.8 million deal to end claims the...

To view the full article, register now.